[HTML][HTML] PET imaging of neuroinflammation in Alzheimer's disease

R Zhou, B Ji, Y Kong, L Qin, W Ren, Y Guan… - Frontiers in …, 2021 - frontiersin.org
Neuroinflammation play an important role in Alzheimer's disease pathogenesis. Advances in
molecular imaging using positron emission tomography have provided insights into the time …

Epilepsy and epileptiform activity in late-onset Alzheimer disease: Clinical and pathophysiological advances, gaps and conundrums

A Kamondi, M Grigg-Damberger, W Löscher… - Nature Reviews …, 2024 - nature.com
A growing body of evidence has demonstrated a link between Alzheimer disease (AD) and
epilepsy. Late-onset epilepsy and epileptiform activity can precede cognitive deterioration in …

[HTML][HTML] Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of …

Y Kong, CA Maschio, X Shi, F Xie, C Zuo… - Molecular …, 2024 - Springer
Reactive astrocytes play an important role in the development of Alzheimer's disease (AD).
Here, we aimed to investigate the temporospatial relationships among monoamine oxidase …

[HTML][HTML] Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F] SDM-8 and [18F] flumazenil PET

Y Kong, L Cao, F Xie, X Wang, C Zuo, K Shi… - Biomedicine & …, 2024 - Elsevier
Purpose Type 2 diabetes mellitus (T2DM) is associated with a greater risk of Alzheimer's
disease. Synaptic impairment and protein aggregates have been reported in the brains of …

[HTML][HTML] Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells

M Robbins - Neural Regeneration Research, 2023 - journals.lww.com
Advances in experimental and computational technologies continue to grow rapidly to
provide novel avenues for the treatment of neurodegenerative disorders. Despite this, there …

The HOPE4MCI study: A randomized doubleblind assessment of AGB101 for the treatment of MCI due to AD

R Mohs, A Bakker… - … Research & Clinical …, 2024 - Wiley Online Library
INTRODUCTION In addition to the accumulation of amyloid plaques and neurofibrillary
tangles, the presence of excess neural activity is a pathological hallmark of Alzheimer's …

Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam

PG Saletti, WB Mowrey, W Liu, Q Li… - Epilepsia …, 2023 - Wiley Online Library
Objective We used the lateral fluid percussion injury (LFPI) model of moderatetosevere
traumatic brain injury (TBI) to identify early plasma biomarkers predicting injury, early post …

[HTML][HTML] Positron emission tomography in animal models of Alzheimer's disease amyloidosis: translational implications

R Ni - Pharmaceuticals, 2021 - mdpi.com
Animal models of Alzheimer's disease amyloidosis that recapitulate cerebral amyloid-beta
pathology have been widely used in preclinical research and have greatly enabled the …

[HTML][HTML] Dynamin-like protein 1 (DNML1) as a molecular target for antibody-based immunotherapy to treat glaucoma

H Tonner, S Hunn, N Auler, C Schmelter… - International journal of …, 2022 - mdpi.com
Slow and progressive loss of retinal ganglion cells (RGCs) is the main characteristic of
glaucoma, the second leading cause of blindness worldwide. Previous studies have shown …

[HTML][HTML] Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery

Y Zhang, L Heylen, M Partoens, JD Mills… - Frontiers in Molecular …, 2022 - frontiersin.org
Synaptic vesicle glycoprotein 2A (SV2A) regulates action potential-dependent
neurotransmitter release and is commonly known as the primary binding site of an approved …